Home / Inspections / 559952

FDA Inspection 559952 — Nesher Pharmaceuticals (USA) LLC

Nesher Pharmaceuticals (USA) LLC — FEI 1922352

The FDA completed an inspection of Nesher Pharmaceuticals (USA) LLC on February 2, 2009 in Bridgeton, MO. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
February 2, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bridgeton, MO (United States)

Facility

Other inspections at this facility

  • 1151199 (VAI Thu Aug 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1092585 (VAI Fri May 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1040785 (NAI Thu Jan 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1002473 (VAI Fri Feb 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 926755 (VAI Thu May 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources